Jpmorgan Chase & CO Inotiv, Inc. Transaction History
Jpmorgan Chase & CO
- $1.51 Trillion
- Q3 2025
A detailed history of Jpmorgan Chase & CO transactions in Inotiv, Inc. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 96,481 shares of NOTV stock, worth $97,445. This represents 0.0% of its overall portfolio holdings.
Number of Shares
96,481
Previous 96,481
-0.0%
Holding current value
$97,445
Previous $135,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
17 transactions
Others Institutions Holding NOTV
# of Institutions
74Shares Held
8.13MCall Options Held
0Put Options Held
0-
Vanguard Group Inc Valley Forge, PA1.4MShares$1.42 Million0.0% of portfolio
-
Balyasny Asset Management LLC Chicago, IL986KShares$995,5930.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny360KShares$363,3610.0% of portfolio
-
Massar Capital Management, LP Stamford, CT350KShares$353,5000.07% of portfolio
-
Vantage Point Financial LLC Lisle, IL337KShares$339,9110.19% of portfolio
About Inotiv, Inc.
- Ticker NOTV
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 25,594,500
- Market Cap $25.9M
- Description
- Inotiv, Inc. provides drug discovery and development services to the pharmaceutical, chemical, and medical device industries; and sells analytical instruments to the pharmaceutical development and contract research industries. It operates through two segments, Contract Research Services and Research Products. The Contract Research Services segme...